CN HEALTH TECH News

Express News | China Health Technology - Bu Xue Re- Designated as an Executive Director

ReutersApr 1 10:08 ET

CN HEALTH TECH: Interim Report 2024

HKEXMar 28 05:36 ET · Announcements

CN HEALTH TECH (01069): Li Zhiqiang has been appointed as the CEO of Genmou Biotechnology.

CN HEALTH TECH Group (01069) announced that Li Zhi Liang has been appointed as the company’s wholly-owned subsidiary Genmou (Shenzhen...

Zhitong FinanceMar 14 07:27 ET

CN HEALTH TECH (01069) announced its interim results, with a net income of 4.978 million yuan, a decrease of 97.53% year-on-year.

CN HEALTH TECH (01069) released its interim results for the six months ending December 31, 2024, the group...

Zhitong FinanceFeb 28 09:36 ET

CN HEALTH TECH: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED 31 DECEMBER 2024

HKEXFeb 28 09:30 ET · Announcements

CN HEALTH TECH (01069.HK) intends to hold a Board of Directors meeting on February 28 to approve the interim results.

On February 18, Glonghui reported that CN HEALTH TECH (01069.HK) announced that the Board of Directors will hold a meeting on February 28, 2025 (Friday) to consider and approve the group's interim performance announcement for the six months ending December 31, 2024, as well as to consider the proposal to pay an interim dividend (if any).

Gelonghui FinanceFeb 18 05:20 ET

China Health Technology Group Holding's (HKG:1069) Profits May Be Overstating Its True Earnings Potential

Simply Wall StNov 9, 2024 19:27 ET

CN HEALTH TECH: Annual Report 2024

HKEXOct 31, 2024 09:41 ET · Announcements

China Health Technology Turns to Profit in FY2024

MT NewswiresSep 30, 2024 21:00 ET

cn health tech group (01069.HK) turned losses into profits, reaching 0.2 billion yuan for the year.

Gelonghui September 30th. cn health tech (01069.HK) announced that the income for the year ended June 30, 2024 was approximately RMB 47.6 million. The attributable profits of the group amounted to approximately RMB 0.2 billion (for the year ended June 30, 2023: a loss of approximately RMB 10.8 million). Basic earnings per share were 29.79 RMB; no dividends are recommended for the 2024 fiscal year. Revenue generated by the group's forestry management business mainly comes from selling logs harvested from the group's forests. Revenue from log sales is recognized when control of the relevant goods is transferred to the customer.

Gelonghui FinanceSep 30, 2024 11:11 ET

Express News | China Health Technology- Profit Attributable for FY2024 RMB200.0 Mln

ReutersSep 30, 2024 11:01 ET

CN HEALTH TECH: ANNOUNCEMENT OF FINANCIAL RESULTSFOR THE YEAR ENDED 30 JUNE 2024

HKEXSep 30, 2024 10:59 ET · Announcements

China Health Technology Group [01069] is now reported at 0.063 Hong Kong dollars, with an increase of 12.50%.

As of 10:13, China Health Technology Group [01069] reported 0.063 Hong Kong dollars, up 0.007 Hong Kong dollars or 12.50% from the previous closing price of 0.056 Hong Kong dollars, with a trading volume of 0.003 million Hong Kong dollars. The highest price today is 0.063 Hong Kong dollars, and the lowest price is 0.062 Hong Kong dollars. Based on the closing price from yesterday, the 10-day average price is 0.08 Hong Kong dollars, and the 50-day average price is 0.06 Hong Kong dollars. The current PE ratio is -0.62 times, and the 14-day relative strength index is 56.48.

Jingu Finance NewsSep 23, 2024 22:13 ET

China Health Technology Group (01069.HK) plans to hold a board of directors meeting on September 30th to approve the annual performance.

China Health Technology Group (01069.HK) announced on September 17th that the board of directors will hold a meeting on September 30th, 2024 (Monday) to review and approve the group's annual performance announcement for the fiscal year ending June 30, 2024, and consider the payment of final dividends (if any).

Gelonghui FinanceSep 17, 2024 04:39 ET

Express News | China Bozza Development - to Place up to 143 Mln Shares at HK$0.043 per Placing Share

ReutersSep 4, 2024 18:10 ET

China Health Technology Group Share Placement Lapses

MT NewswiresJul 8, 2024 07:14 ET

China Health Technology Group (01069.HK): New share issuance under general authorization is invalidated.

China Health-Tech Group (01069.HK) announced on July 8th that the conditions under the placement agreement were not met before July 5th, 2024. Therefore, the placement agreement did not become unconditional and expired on July 5th, 2024. Pursuant to the placement agreement, all obligations and responsibilities of the counterparties in relation to the placement matter will be terminated, and except for any prior breach, no counterparty shall make any claim against any other party in respect of any matter arising out of or in connection with the placement matter.

Gelonghui FinanceJul 8, 2024 00:09 ET

China Health Technology Hires Auditor

MT NewswiresJun 17, 2024 03:14 ET

China Health Technology Group Limited (01069.HK) appoints Zhongzhi Xin (Hong Kong) as its new auditor.

China Health Technology Group (01069.HK) announced on June 14 that the board of directors has appointed Zhongzhi Xing (Hong Kong) Certified Public Accountants Limited ("Zhongzhi Xing (Hong Kong)") as the company's new auditor.

Gelonghui FinanceJun 14, 2024 07:05 ET

China Health Technology to Place 143 Million Shares for HK$9 Million

MT NewswiresMay 28, 2024 21:44 ET